OppenheimerFunds’s Parexel International Corp PRXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-14,893
Closed -$1.31M 1919
2017
Q3
$1.31M Sell
14,893
-7,261
-33% -$636K ﹤0.01% 1074
2017
Q2
$1.93M Buy
22,154
+11,610
+110% +$866K ﹤0.01% 943
2017
Q1
$666K Buy
10,544
+3,878
+58% +$256K ﹤0.01% 1365
2016
Q4
$438K Buy
6,666
+1,785
+37% +$112K ﹤0.01% 1442
2016
Q3
$339K Sell
4,881
-227
-4% -$15.3K ﹤0.01% 1449
2016
Q2
$321K Buy
5,108
+423
+9% +$26.2K ﹤0.01% 1438
2016
Q1
$294K Sell
4,685
-369
-7% -$22.7K ﹤0.01% 1460
2015
Q4
$344K Buy
+5,054
New +$329K ﹤0.01% 1457

Other funds holding PRXL

OppenheimerFunds's PRXL Position: Q4 2017 in Review

OppenheimerFunds sold out of Parexel International Corp (PRXL) in Q4 2017, closing a stake of 14,893 shares — an estimated $1.31M sold.

OppenheimerFunds first reported a position in PRXL in Q4 2015 and held it in 8 quarters. The position peaked at $1.93M in Q2 2017. 1 fund tracked by Wall St. Rank holds PRXL as of Q4 2017.

  • OppenheimerFunds reported no remaining Parexel International Corp position as of Q4 2017 after selling out during the quarter.
  • OppenheimerFunds sold 14,893 Parexel International Corp shares in Q4 2017, an estimated $1.31M.
  • OppenheimerFunds first reported a position in Parexel International Corp in Q4 2015 and held it in 8 quarters.
  • OppenheimerFunds's Parexel International Corp position peaked at $1.93M in Q2 2017.
  • 1 fund tracked by Wall St. Rank held Parexel International Corp as of Q4 2017.

Based on OppenheimerFunds's 13F filing for Q4 2017, filed 12 Feb 2018.